findmyKOL

Parth Rali, MD

Enriched profile

Professor of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University · Temple University Hospital

ORCID↗NPI↗
✓ Full profile
Region🇺🇸 Philadelphia, PA · Northeast · United StatesSpecialtyPulmonary DiseaseFocusVenous Thromboembolism Diagnosis and Management+4
Active KOLfindmyKOL type: EliteLatest publication2025Online presenceverified 2026Payments2021–2025NIH fundingNone on fileWhy? →

Parth Rali is Professor of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University at Temple University Hospital. OpenAlex indexes 185 publications with 2,280 citations (h-index 18); ClinicalTrials.gov lists 3 registered studies with this person as an investigator.

Data verified 12 Oct 2026

Overview

Updated 14 Oct 2026

Parth Rali, MD, is Professor of Thoracic Medicine and Surgery, Lewis Katz School of Medicine at Temple University at Temple University Hospital / Lewis Katz School of Medicine at Temple University. The public record shows 185 publications with 2,280 citations (h-index 18), centered on Venous Thromboembolism Diagnosis and Management, Pulmonary Hypertension Research and Treatments, Cardiovascular and Diving-Related Complications. It also documents an investigator role on 3 registered clinical trials, industry payments reported by 20 companies.

  • Most recent indexed publication: 2025 · Circulation
  • Top research focus: Venous Thromboembolism Diagnosis and Management
  • 3 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 20 companies

Generated from the cited public record · current as of 14 Oct 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Idiopathic Pulmonary Fibrosis2 trialsLung Diseases, Interstitial2 trialsPulmonary Hypertension1 trialHypertension1 trialPulmonary Embolism1 trialEmbolism1 trialStroke

Research focus

OpenAlex concept fingerprint
Venous Thromboembolism Diagnosis and ManagementPulmonary Hypertension Research and TreatmentsCardiovascular and Diving-Related ComplicationsAcute Ischemic Stroke ManagementAcute Myocardial Infarction Research

Drugs & molecules

across trials, industry payments and publications
Xareltogeneric · RivaroxabanClinical trials—Industry payments54Publications—Winrevairgeneric · SotaterceptClinical trials—Industry payments20Publications—Tyvasogeneric · TreprostinilClinical trials—Industry payments19Publications—Uptravigeneric · SelexipagClinical trials—Industry payments16Publications—Opsumitgeneric · MacitentanClinical trials—Industry payments13Publications—Arikaycegeneric · AmikacinClinical trials—Industry payments3Publications—XenletaClinical trials—Industry payments3Publications—Breztrigeneric · Budesonide / formoterol / glycopyrroniumClinical trials—Industry payments2Publications—Fasenrageneric · BenralizumabClinical trials—Industry payments1Publications—NirmatrelvirClinical trials—Industry payments1Publications—Nucalageneric · MepolizumabClinical trials—Industry payments1Publications—Opsynvigeneric · Macitentan / tadalafilClinical trials—Industry payments1Publications—

Works with

trial sponsors and companies reporting payments
Inari Medical, Inc.Clinical trials—Industry payments143Janssen Pharmaceuticals, IncClinical trials—Industry payments54Merck Sharp & Dohme LLCClinical trials—Industry payments35Stryker CorporationClinical trials—Industry payments22Actelion Pharmaceuticals US, Inc.Clinical trials—Industry payments17United Therapeutics CorporationClinical trials—Industry payments15AstraZeneca Pharmaceuticals LPClinical trials—Industry payments4Cardinal Health 200 LLCClinical trials—Industry payments4AngioDynamics, Inc.Clinical trials—Industry payments3Insmed, Inc.Clinical trials—Industry payments3Nabriva Therapeutics, plcClinical trials—Industry payments3Penumbra, Inc.Clinical trials—Industry payments3AbiomedClinical trials—Industry payments2Aidoc Medical LtdClinical trials—Industry payments2Genentech USA, Inc.Clinical trials—Industry payments1GlaxoSmithKline, LLC.Clinical trials—Industry payments1Harmony Biosciences LLCClinical trials—Industry payments1Pfizer Inc.Clinical trials—Industry payments1Sandoz Inc.Clinical trials—Industry payments1Temple UniversityClinical trials1Industry payments—Tempus AIClinical trials1Industry payments—United TherapeuticsClinical trials1Industry payments—Viz.ai, Inc.Clinical trials—Industry payments1

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
185publications

Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.

2,280citations

Total citations across indexed works.

18h-index

Hirsch index (OpenAlex). i10-index 24.

Clinical & industry

trials, payments and federal funding
3clinical trials

Investigator role on registered studies.

View trials ↓
20companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
0NIH grants

Federally funded research awards.

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 14 Oct 2026

Listed as an investigator on 3 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 14 Oct 2026

20 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Respiratory

    61.6%
    Corticosteroid20.3%
    Trelegy Ellipta61%Breo Ellipta30%Symbicort9%
    Part D<11 patients
    beta2-Adrenergic Agonist19%
    Albuterol Sulfate Hfa91%Ventolin Hfa9%
    Part D<11 patients

    + 7 more classes in this area

  • Metabolism & gastrointestinal

    7.8%
    Corticosteroid5.8%
    Prednisone100%
    Part D≥25 patients
    Proton pump inhibitor2%
    Omeprazole100%
    Part D<11 patients
  • Cardiovascular

    7.1%
    Activin Signaling Inhibitor4.9%
    Winrevair100%
    Part D<11 patients
    Loop diuretic2.1%
    Furosemide100%
    Part D<11 patients
All 8 therapeutic areas: search, sort and filter.Explore →
Where care is delivered (Part B)76.6% facility · 23.4% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →

Publications

Updated 14 Oct 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 14 Oct 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Riyaz Bashir36Ka U. Lio33Gerard J. Criner32Joseph N. Panaro29Shameek K. Gayen28Vladimir Lakhter26Huaqing Zhao24Gerald J. Criner24Gary Cohen22Rohit Gupta18Samantha Pettigrew17Matthew Zheng16Rami Alashram13David Jiménez12Ibraheem Yousef11O.A. O’Corragain11Belinda N. Rivera‐Lebron9Daniel C. Sacher9Shari B. Brosnahan9Maruti Kumaran8Robert M. Marron8T.-A.A. Ho8Maulin Patel8Maruti Kumaran8S Gayen8Ryan Cobb7Sheila Weaver7Charles B. Ross7S E Weaver7M Naranjo Tovar7Andrew J. Gangemi6Parag Desai6Bilal Haider Lashari6J. Moore6Chandra A. Dass6Eneida Male6Gilbert E. D’Alonzo6Maruti Kumaran6Giorgi Chilingarashvili6E.-O. Essien6

Online presence

Updated 14 Oct 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/parth-rali-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗
  • LinkedIn

    linkedin.com/in/parth-rali-bb89002b9

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
  • ResearchGate

    researchgate.net/scientific-contributions/Parth-Rali-2107733755

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →researchgate.net ↗

Mentions by others

where others cite or feature them
  • Other

    templehealth.org/about/news/in-the-media/dr-parth-rali-joins-consultant360s-podcast360-to-discuss-research-presented-at-chest-2021-on-the-diagnosis-and-management-of-acute-pulmonary-embolism

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 14 Oct 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MBBS

    SVIMSAR Medical College, Gujarat, India

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
  • Board certified

    Internal Medicine (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
  • Board certified

    Pulmonary Disease (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
  • Board certified

    Critical Care Medicine (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗

Editorial & leadership roles

journal and society appointments
  • Fellow

    American College of Chest Physicians

    2024
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
  • Chair

    National PERT Consortium Protocol Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
  • Incoming Vice Chair

    CHEST Pulmonary Vascular and Cardiovascular Network

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
  • Director

    TUHS Pulmonary Embolism Response Team (PERT) Program

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
  • Chair

    TUHS Anticoagulation Stewardship Committee

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗

Awards & honors

honors on the public record
  • Top Doctors

    Pulmonary Disease, Philadelphia magazine

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗
  • Distinguished Educator Award

    American College of CHEST Physicians

    2023
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →templehealth.org ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.